KalVista Pharmaceuticals common shares delisted from Nasdaq after Chiesi acquisition closes
KalVista Pharmaceuticals completed its acquisition by Chiesi Farmaceutici S.p.A.
$27.0077.8%June 11, 2026
Company
SEC filing news and material events for KalVista Pharmaceuticals, Inc., briefed from primary-source filings.
1 story
KalVista Pharmaceuticals completed its acquisition by Chiesi Farmaceutici S.p.A.